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The pseudoglycosyltransferase (PsGT) VldE is a
glycosyltransferase-like protein that is similar to
trehalose 6-phosphate synthase (OtsA). However,
in contrast to OtsA, which catalyzes condensation
between UDP-glucose and glucose 6-phosphate,
VldE couples two pseudosugars to give a product
with an a,a-N-pseudoglycosidic linkage. Despite
their unique catalytic activity and important role in
the biosynthesis of natural products, little is known
about the molecular basis governing their substrate
specificity and catalysis. Here, we report compara-
tive biochemical and kinetic studies using recombi-
nant OtsA, VldE, and their chimeric proteins with
a variety of sugar and pseudosugar substrates. We
found that the chimeric enzymes can produce hybrid
pseudo-(amino)disaccharides, and an amino group
in the acceptor is necessary to facilitate a coupling
reaction with a pseudosugar donor. Furthermore,
we found that the N-terminal domains of the enzymes
not only play a major role in selecting the acceptors,
but also control the type of nucleotidyl diphosphate
moiety of the donors.
INTRODUCTION
Glycosyltransferases (GTs, EC 2.4.x.y) are enzymes that cata-
lyze the transfer of a sugar moiety from an activated sugar donor
onto a sugar acceptor or an aglycone, resulting in sugar-contain-
ing products. GTs are widely distributed in nature, and play a
central role in the structural and physiological aspects of living
organisms; they are involved in the synthesis of oligosaccha-
rides, polysaccharides, glycoproteins, glycolipids, glycosylated
natural products, and many others (Breton et al., 2006; Elsha-
hawi et al., 2015; Wagner and Pesnot, 2010). Consequently,
there are currently more than 150,000 genes believed to encode
members of the >90 families of GTs listed in the databases
(NCBI, CAZy; http://www.cazy.org), and this number is growing
rapidly (Hansen et al., 2010).
Despite the large number of families of GTs with diverse
primary sequences and functions, to date only two distinct struc-
tural folds are known for most nucleotide sugar-dependent GTs:
GT-A and GT-B folds. The GT-A fold is characterized by a single
domain fold, made up of an a/b/a sandwich (a seven-stranded724 Chemistry & Biology 22, 724–733, June 18, 2015 ª2015 Elsevierb-sheet core flanked by a helices) that resembles a Rossmann
fold (Breton et al., 2006). The central b sheet is flanked by a small
antiparallel b sheet connected by a metal-coordinating DXD
motif-containing loop, and together they form the active site
(Chang et al., 2011). On the other hand, the crystal structures
of GT-B GTs revealed that they consist of two distinct b/a/b
Rossmann-like domains in non-abutting opposing orientation,
with a catalytic site located between the domains. The N-termi-
nal domain is responsible for the acceptor binding, whereas the
C-terminal domain is responsible for nucleotide donor binding
(Chang et al., 2011; Vrielink et al., 1994).
Recently, we discovered a number of putative GTs that can
catalyze non-glycosidic C-N couplings in the biosynthesis of
pseudosugar-containing natural products, such as the a-gluco-
sidase inhibitors acarbose and amylostatins, the antibiotic pyra-
lomicin 1a, and the antifungal agent validamycin A (Figure 1)
(Asamizu et al., 2013, 2011; Flatt et al., 2013). The term ‘‘pseudo-
sugars’’ refers to analogs of monosaccharides in which the ring
oxygen has been replaced by amethylene group (Barbaud et al.,
1995; Barton et al., 1988; Brunkhorst et al., 1999; Callam and
Lowary, 2000; Suami and Ogawa, 1990; Yoshikawa et al.,
1994). The enzymes that catalyze the transfer of pseudosugars,
or pseudoglycosyltransferases (PsGTs), are believed to have
evolved from ancestral GTs. Our recent studies on VldE,
a trehalose 6-phosphate synthase (TPS)-like protein from the
validamycin biosynthetic pathway, revealed that the enzyme
does not catalyze the coupling between uridine diphosphate
(UDP)-glucose and glucose 6-phosphate, but catalyzes an
unprecedented non-glycosidic C-N coupling of guanosine
diphosphate (GDP)-valienol and validamine 7-phosphate to
give validoxylamine A 70-phosphate with an a,a-amino linkage
(Figure 2) (Asamizu et al., 2011). This finding raises fundamental
questions as to how a GT-like enzyme catalyzes a condensation
of two non-sugar molecules with retention of configuration.
The current paradigm suggests that retaining GTs, such as the
GT family-20 TPS (OtsA) and family-5 glycogen synthases
(based on the CAZy classification), function via an internal return
(SNi)-like mechanism involving an oxocarbenium ion-like transi-
tion state, as opposed to a double SN2 displacementmechanism
(Lairson et al., 2008; Lee et al., 2011). Seminal X-ray crystallog-
raphy and linear free energy relationship studies by Davis and
coworkers on OtsA using validoxylamine A 70-phosphate as a
transition state mimic demonstrate the involvement of a front-
face nucleophilic attack involving hydrogen bonding between
the leaving group (UDP) and the nucleophile (acceptor sugar),
in the OtsA reaction (Errey et al., 2010; Lee et al., 2011). The
leaving-group phosphate is proposed to act as a base to deprot-
onate the acceptor. Furthermore, kinetic isotope effects indicateLtd All rights reserved
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Figure 1. Chemical Structures of Pseudosu-
gar-Containing Natural Productsthe participation of a highly dissociative oxocarbenium ion-like
transition state in the reaction (Lee et al., 2011). However, as
the donor substrate for VldE is an activated pseudosugar
(GDP-valienol), oxocarbenium ion formation is not possible in
the VldE-catalyzed coupling reaction. Moreover, little is known
about the molecular basis governing PsGT substrate specificity
and catalytic mechanism, andwhether or not the amino group on
the acceptor is necessary for the reaction to occur. To investi-
gate the substrate specificity and catalytic mechanism of VldE
and its relationship with OtsA, we carried out careful biochemical
and kinetic studies of recombinant VldE, OtsA, and their chimeric
proteins, which were engineered by swapping the N- and C-ter-
minal domains of the two proteins, with a variety of synthetically
prepared sugar (pseudosugar) donor and acceptor substrates.
Here, we report new insights into the distinct substrate speci-
ficity and catalytic activities of OtsA and VldE and their chimeric
proteins.
RESULTS
Comparative Analysis of VldE, Escherichia coli OtsA,
and Streptomyces coelicolor OtsA
The PsGT VldE is highly similar to the TPS OtsA. X-Ray crystal
structures of VldE from Streptomyces hygroscopicus subsp.
limoneus and the well-studied UDP-forming Escherichia coli
TPS (OtsA(Eco)) demonstrated that both proteins adopt a
GT-B fold with the C-terminal domain generally accepted to be
the one that recognizes a nucleotidylated sugar donor and the
N-terminal domain recognizes a sugar acceptor, with the do-
mains connected by a linker (Cavalier et al., 2012; Gibson
et al., 2002). It has been reported that OtsA utilizes a sequential
ordered bi-bi mechanism in which UDP-glucose (the sugar
donor) binds to the active site first and is followed by glucose
6-phosphate (the sugar acceptor) (Lee et al., 2011). The
conserved architectural structures of VldE and OtsA with two
distinct substrate binding domains provide an unusual opportu-
nity to investigate their catalytic properties through domain
swapping. Therefore, we set out to create chimeric proteins of
VldE and OtsA and investigate the effects of each domain onChemistry & Biology 22, 724–733, June 18, 2015the substrate specificity and catalytic
activities of the proteins. However, direct
comparisons of the primary amino acid
sequences of VldE with OtsA(Eco) only
showed 23% identity between the two
proteins. On the other hand, TPS from
the model soil bacterium Streptomyces
coelicolor (OtsA(Sco)) is more similar to
VldE (29% identity and 45% similarity).
However, no detailed biochemical
studies of this enzyme have been re-
ported in the literature.
To confirm the catalytic function of
OtsA(Sco), the genewas cloned in pRSET
B and expressed in E. coli BL21(DE3)pLysS. Characterization of the recombinant protein with GDP-,
ADP-, UDP-, cytidine diphosphate (CDP)-, and deoxythymidine
diphosphate (dTDP)-glucose individually as sugar donor and
glucose 6-phosphate as sugar acceptor revealed that OtsA(Sco)
prefers ADP-glucose (Km = 0.459 ± 0.05 mM; kcat/Km =
4.57 s1 mM1) and GDP-glucose (Km = 0.681 ± 0.077 mM;
kcat/Km = 3.77 s
1 mM1) as sugar donors (Figures 4 and S5;
Table 1). To some extent, the enzyme also processes UDP-
glucose (Km >1.5 mM) and CDP-glucose (Km >4 mM), albeit
with much lower binding affinity. No product can be detected in
the reaction with dTDP-glucose (Figure S1).
Whereas OtsA(Sco) has broad substrate specificity, recog-
nizing GDP-, ADP-, UDP-, and CDP-glucose as sugar donors,
VldE was only known to recognize GDP-valienol as a pseudosu-
gar donor. No other nucleoside diphosphate (NDP)-valienols
have previously been tested, because the corresponding
nucleotidyltransferase enzyme VldB appeared to prefer GTP as
substrate, and produces GDP-valienol (Yang et al., 2011). The
preference of VldE toward GDP-valienol was also supported
by its X-ray crystal structures (Cavalier et al., 2012). However,
it was unclear whether VldE can process other NDP-valienols.
Therefore, we prepared all five possible NDP-valienols and eval-
uated the substrate preference of VldE, whether or not it can
process other NDP-valienols. GDP-, ADP-, and CDP-valienols
were prepared from valienol 1-phosphate and their correspond-
ing nucleotidyl triphosphates (GTP, ATP, or CTP), using VldB
(Yang et al., 2011), whereas UDP- and dTDP-valienol were
prepared from valienol 1-phosphate and UTP and deoxythymi-
dine triphosphate (dTTP), respectively, using RmlA-L89T, an
engineered broad-spectrum nucleotidyltransferase (Moretti
et al., 2011), kindly provided by Prof. Jon Thorson at the Univer-
sity of Kentucky (Figures S2A and S2B). Although RmlA-L89T
has been known to have relaxed substrate specificity toward
various sugar phosphates (Moretti et al., 2011), the present study
showed that RmlA-L89T is also able to process an unsaturated
carbasugar phosphate. Incubation of VldE with NDP-valienols
and validamine 7-phosphate revealed that VldE only accept
GDP-valienol as substrate (Figure S2C). Based on the similar
GDP-sugar substrates, high sequence similarity, and theirª2015 Elsevier Ltd All rights reserved 725
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Figure 2. Catalytic Activities of VldE and OtsA
(A) VldE couples two pseudosugars to give a product with an a,a-N-pseudo-
glycosidic linkage.
(B) OtsA catalyzes condensation between UDP-glucose and glucose 6-
phosphate.
See also Figures S1 and S2A–S2C.Streptomyces origin, we selected OtsA(Sco) for domain-swap-
ping experiments with VldE.
Design and Construction of VldE/OtsA(Sco) Chimeras
Guided by the crystal structures of VldE and predicted second-
ary structure and folding of OtsA(Sco)—as its crystal structures
are not yet available—we designed chimeric PsGTs using these
two proteins. Secondary structure and protein folding prediction
were performed using the Phyre2 program (http://www.sbg.bio.
ic.ac.uk) (Figures S3A and S3B) (Kelley and Sternberg, 2009).
The sites for domain swapping were chosen within loops (be-
tween amino acid residues Thr275 and Glu276 of OtsA(Sco)
and residues Gly266 and Arg267 of VldE), which are located in
the linker regions of the two proteins. We chose these positions
with the expectation that the secondary structures of the N- and
C-terminal domains would not be disrupted and that they pro-
vide the least interruption of the tertiary protein structure (Fig-
ure 3A). The model structures of the expected chimeric proteins
were then reanalyzed using Phyre2. The results showed that
the modeled structures for chimera-1 (N terminus of VldE,
C terminus of OtsA(Sco)) and chimera-2 (N terminus of
OtsA(Sco), C terminus of VldE) (Figure 3B) share 71% and
61% similarity, respectively, with that of VldE, with 100% confi-
dence (Figure 3B) (Kelley and Sternberg, 2009). The DNA
fragments representing the N- and C-terminal domains of the
enzymes were then amplified by PCR; the N-terminal fragment
from one parental gene was replaced with an equivalent frag-
ment of the second parental gene and vice versa. As no conve-
nient restriction sites are available within the desired region of the
genes, cloning of the chimeric genes was performed by blunt726 Chemistry & Biology 22, 724–733, June 18, 2015 ª2015 Elsevierend ligations between the two fragments, and the products
were ligated to the pRSET B vector (Figure 3C). The genes
were expressed in E. coliBL21(DE3) pLysS, providing soluble re-
combinant chimera-1 and chimera-2 (Figure 3D).
Chimera-1 Can Produce a Hybrid
Pseudoaminodisaccharide
Chimera-1, together with VldE and OtsA(Sco), were character-
ized using either GDP-valienol or GDP-glucose as the sugar
donor and validamine 7-phosphate or glucose 6-phosphate as
the sugar acceptor. Both GDP-valienol and validamycin 7-phos-
phate were prepared according to procedures reported previ-
ously (Asamizu et al., 2011). As expected, chimera-1 was able
to catalyze the coupling between GDP-glucose and validamine
7-phosphate to give a hybrid pseudoaminodisaccharide with
an apparent Km value of 1.1 ± 0.07 mM and kcat/Km 0.15 s
1
mM1 for GDP-glucose, and Km 0.975 ± 0.1 mM and kcat/Km
0.11 s1 mM1 for validamine 7-phosphate (Figures 4K, S5E,
and S5F). Negative-ionmode electrospray ionizationmass spec-
trometry (ESI-MS) analysis of the new product gave an m/z of
418 [M  H], consistent with the expected pseudoaminodisac-
charide phosphate product (Figure S4A). Moreover, addition of
the phosphatase VldH to the reaction mixture resulted in a de-
phosphorylated product, which showed an m/z of 340 [M + H]+
in positive ESI-MS mode. This compound was further confirmed
by tandem mass spectrometry analysis, which gave fragment
ions at 322, 310, 294, and 178 (Figure S4B), indicating the
presence of validamine moiety in the product. This hybrid pseu-
doaminodisaccharide product is relatively unstable, readily de-
grading under the reaction conditions. Prolonged incubation
(more than 1 hr) resulted in a significant reduction of the product
intensity in the ESI-MS. As a result, numerous attempts to isolate
the compound from the reaction mixtures were unsuccessful.
Interestingly, chimera-1 can also catalyze the coupling be-
tween GDP-valienol and validamine 7-phosphate (Figure 4C),
albeit with a much lower conversion rate. The enzyme affinity to
GDP-valienol (Km >10 mM) is significantly lower than to GDP-
glucose (Km 1.1 ± 0.07 mM), indicating that GDP-valienol is not
a preferred substrate for chimera-1 (Figure 5). This is consistent
with the fact that chimera-1 contains the OtsA C-terminal
domain. However, when GDP-valienol was used as a donor in
the parent proteinOtsA(Sco), with either validamine 7-phosphate
or glucose 6-phosphate as acceptor, no products could be
observed (Figures 4B and 4N), suggesting that the C-terminal
domain of OtsA can only accept GDP-valienol (a pseudosugar)
as substrate when it is fused with the N-terminal domain of VldE.
Chimera-2 Displays OtsA Activity
As chimera-2 consists of the N-terminal domain of OtsA(Sco)
and the C-terminal domain of VldE, the protein was incubated
with GDP-valienol and glucose 6-phosphate. It is expected
that this reaction would furnish a hybrid product similar to that
of chimera-1, except in a reverse combination. However, we
discovered that chimera-2 is unable to process the two sub-
strates to produce the desired product (Figure 4P). Nor can
it catalyze the coupling between GDP-valienol and validamine
7-phosphate (Figure 4D). However, interestingly, the protein is
able to catalyze the condensation of GDP-glucose and glucose
6-phosphate to give trehalose 6-phosphate (Figures 4H andLtd All rights reserved
Table 1. Kinetics Data for OtsA(Sco), VldE, Chimera-1, and Chimera-2
Kinetic Parameters
OtsA(Sco)
GDP-Glucose Glucose-6P ADP-Glucose Glucose-6P Validol-7P
Km (mM) 0.681 ± 0.077 0.587 ± 0.11 0.459 ± 0.05 0.79 ± 0.13 >10
kcat (s
1) 2.5 ± 0.12 0.815 ± 0.05 2.1 ± 0.1 1.18 ± 0.08 –
kcat/Km (s
1 mM1) 3.77 1.39 4.57 1.5 –
VldE
GDP-Valienola Validamine-7Pa GDP-Glucose
Km (mM) 0.06 ± 0.012 0.308 ± 0.035 >2.2
kcat (s
1) 0.12 ± 0.012 0.12 ± 0.007 –
kcat/Km (s
1 mM1) 2.0 0.39 –
Chimera-1
GDP-Glucose Validamine-7P GDP-Valienol
Km (mM) 1.1 ± 0.07 0.975 ± 0.1 >10
kcat (s
1) 0.166 ± 0.003 0.11 ± 0.0035 –
kcat/Km (s
1 mM1) 0.151 0.11 –
Chimera-2
GDP-Glucose Glucose-6P Validol-7P
Km (mM) 3.56 ± 0.38 6.44 ± 0.95 4.95 ± 0.7
kcat (s
1) 2.9 ± 0.134 0.843 ± 0.067 0.58 ± 0.038
kcat/Km (s
1 mM1) 0.814 0.131 0.12
See also Figure S5.
aData adapted from Asamizu et al. (2011).S4C), suggesting that theC-terminal domain of chimera-2, which
originates from VldE, is able to recognize GDP-glucose (Km
3.56 ± 0.38 mM) as substrate.
VldE Prefers GDP-Valienol over GDP-Glucose as
Substrate
The ability of chimera-2 to process GDP-glucose and glucose
6-phosphate has urged us to reinvestigate the substrate
specificity of VldE andwhether VldE itself can process these sub-
strates. The enzyme was incubated with GDP-glucose and
glucose 6-phosphate, as well as with GDP-glucose and valida-
mine 7-phosphate. The reaction was terminated after 1 hr and
the products were immediately analyzed by ESI-MS. While incu-
bation of VldE with GDP-glucose and glucose 6-phosphate did
not give any product (Figure 4E), it can in fact process GDP-
glucose and validamine 7-phosphate to give a product (m/z 418
[M  H]) (Figures 4I and S4A), which is identical to that of
chimera-1.Asdescribedabove, thishybridcompound is relatively
unstable, requiring early termination of incubation and immediate
analysis of the sample for clear observation of the product. Its low
stability may explain why this product was not observed in our
previous experiments (Asamizu et al., 2011). In light of the present
results, we conclude that the C-terminal domain of VldE can
recognize both GDP-valienol (Km 0.06 ± 0.012 mM) (Asamizu
et al., 2011) and GDP-glucose (Km >2.2 mM) as substrate, but
with >37-fold greater affinity toward GDP-valienol.
The Role of the N-Terminal Domain in Governing
the Type of Bonding
One of the differences between OtsA and VldE is that OtsA cata-
lyzes the formation of a glycosidic bond (C-O bond), whereasChemistry & Biology 22,VldE forms a nitrogen linkage (C-N bond). Based on the results
of our biochemical studies of chimera-1 and chimera-2, we
concluded that the N-terminal domains of VldE and OtsA(Sco)
have more rigid substrate specificity or are mechanistically
more restricted than their C-terminal domains. Chimera-1, which
contains the N-terminal domain of VldE, only recognizes valida-
mine 7-phosphate, but not glucose 6-phosphate, whereas
chimera-2, which contains the N-terminal domain of OtsA, only
recognizes glucose 6-phosphate, but not validamine 7-phos-
phate, as an acceptor molecule. To confirm whether this rigid
substrate specificity is also observed in the parent proteins, we
incubated VldE with GDP-valienol and glucose 6-phosphate
(Figures 4M and S4C), and OtsA(Sco) with GDP-glucose and
validamine 7-phosphate (Figures 4J and S4D). As expected,
both reactions did not give any desired products (Figure S4C
and S4D), confirming that the N-terminal domains of VldE and
OtsA(Sco) play a significant role in governing the type of sub-
strates and/or catalytic reactions. However, whether this is due
to the differences in nucleophilicity (-OHversus -NH2) or the pres-
ence of a ring oxygen (sugar versus cyclitol) of the acceptor mol-
ecules was unclear.
Amino Group Is Necessary for Pseudoglycoside
Formation
To investigate whether nucleophilicity or the presence of a ring
oxygen of the acceptor molecule plays a bigger role in the
coupling reaction, we synthesized validol 7-phosphate, a valida-
mine 7-phosphate analog inwhich theC-1 amino group has been
replacedwith a hydroxy group, and used it as the acceptormole-
cule. The compound was synthesized from tetrabenzylvalidone
(Asamizu et al., 2011) following a procedure shown in Figure S4E.724–733, June 18, 2015 ª2015 Elsevier Ltd All rights reserved 727
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chimera-2 in the presence of either GDP-valienol or GDP-
glucose. The results showed that chimera-1 did not recognize
validol 7-phosphate as acceptor molecule, indicating that the
amino group is critical for the PsGT reaction (Figures 4S and
S4F). On the other hand, chimera-2 can only catalyze the
coupling between GDP-glucose and validol 7-phosphate (Fig-
ure 4T), but not between GDP-valienol and validol 7-phosphate
(Figure S4F), which is in agreement with the notion that the amino
group is required for the pseudoglycosidic coupling to occur.
This was further confirmed by testing validol 7-phosphate with
the parent proteins VldE and OtsA. As expected, VldE was not
able to catalyze the coupling between GDP-valienol and validol
7-phosphate (Figure 4Q), whereas OtsA was able to couple
GDP-glucose and validol 7-phosphate to give a hybrid product
(Figure 4R), a,a-pseudotrehalose 70-phosphate, which upon
VldH hydrolysis gave a,a-pseudotrehalose (Figure S4G) (Bock
et al., 1991). Although OtsA can recognize validol 7-phosphate
as substrate, kinetic studies of OtsA with GDP-glucose and
validol 7-phosphate revealed the enzyme affinity to validol
7-phosphate (Km >10 mM) is significantly lower than to glucose
6-phosphate (Km 0.587 ± 0.11 mM) (Figure 5; Table 1).
Based on these results, we proposed that strong nucleophilic
character is key for pseudoglycoside formation involving GDP-728 Chemistry & Biology 22, 724–733, June 18, 2015 ª2015 Elseviervalienol, and that in the OtsA reaction the ring oxygen in the
sugar acceptor (glucose 6-phosphate) plays a significant role
for the glycosylation reaction to take place efficiently.
VldE Recognizes 1-Amino-1-Deoxyglucose
6-Phosphate as an Acceptor Molecule
To further confirm the importance of amino group in pseudogly-
coside formation, we tested 1-amino-1-deoxyglucose 6-phos-
phate, which resembles glucose 6-phosphate but with an amino
group at the anomeric (C-1) position, as sugar acceptor. This
compound was prepared by stirring glucose 6-phosphate in
600 mM ammonium acetate at room temperature for 2 days
(Lim et al., 2006; Vetter and Gallop, 1995). Incubation of VldE
with GDP-valienol and 1-amino-1-deoxyglucose 6-phosphate,
however, did not give the expected product pseudoaminotreha-
lose (Figure S6A). Interestingly, careful analysis of the reaction
mixture by ESI-MS and high-performance liquid chromatog-
raphy (HPLC) revealed the presence of valienamine, a hydrolytic
product of validoxylamine A and the synthetic precursor of the
antidiabetic drug voglibose. No valienamine was observed in
the reaction with boiled enzyme, indicating that the compound
is produced from an enzymatic reaction (Figures S6A and
S6B). Therefore, we postulated that the coupling reaction be-
tween GDP-valienol and 1-amino-1-deoxyglucose 6-phosphateLtd All rights reserved
did occur and that the product, pseudoaminotrehalose, is then
hydrolyzed to valienamine via an imine intermediate (Figure 6).
The N-Terminal Domain Plays a Significant Role in the
NDP-Sugar Preference of VldE and OtsA
X-Ray crystal structures of OtsA(Eco) and VldE bound to UDP
and GDP, respectively, demonstrated the sites and specific
NDP binding pockets in the C-terminal domains of the enzymes,
which is consistent with the notion that the C-terminal domains
determine the selection of the NDP-sugar or NDP-cyclitol
substrates. However, incubations of chimera-1 or chimera-2
with GDP-, ADP-, UDP-, CDP-, and dTDP-glucose individually
with their corresponding acceptor molecules revealed that
chimera-1, which contains the C-terminal domain of OtsA(Sco),
can only process GDP-glucose (similar to VldE) (Figure S4H),
whereas chimera-2, which contains the C-terminal domain of
VldE, can accept all NDP-glucoses except dTDP-glucose
as substrates, similar to OtsA(Sco) (Figure S4H). These are
completely opposite to the NDP specificity of the parent proteins
from which the C-terminal domains originate. Therefore, in
contrast to the current paradigm for GT-B GTs, the results
strongly suggest that the N-terminal domains of OtsA and
VldE play a significant role in selecting the type of nucleotidyl
diphosphate moiety of the donor sugars.
DISCUSSION
Based on their X-ray crystal structures, OtsA and VldE are group-
ed into the GT-B structural type. The conserved architectural
structures of this group of proteins with two distinct substrate
binding domains have made them an attractive target for
domain-swapping-based engineering. Domain swapping is a
common strategy for engineering proteins that have distinct
catalytic or substrate binding regions. Therefore, conceptually
it is a promising and attainable approach for mechanistic studies
or diversification of GT-B type GTs. However, in practice this
approach is not always straightforward, as identifying ideal
recombination sites within two different GTs and preserving
their catalytic functions are sometimes challenging. Neverthe-
less, numerous successful constructions of functional chimeric
GTs have been reported over the past 15 years, most notably
those from the urdamycin pathway UrdGT1b and UrdGT1c
(Hoffmeister et al., 2001), the plant flavonoid GTs UGT74F1
and UGTT74F2 (Cartwright et al., 2008), and the glycopeptide
GTs GtfB and Orf10* (Truman et al., 2009). However, all of these
GT pairs are highly homologous and perform analogous glyco-
sylations; UrdGT1b and UrdGT1c share 91% sequence identity,
UGT74F1 and UGTT74F2 possess 76% identity, and GtfB
and Orf10* share 70% identity. On the other hand, VldE and
OtsA(Sco) only share 29% amino acid sequence identity. There-
fore, our success in constructing functional chimeras from these
two proteins is a rather fortunate event. More importantly, it pro-
vides evidence that both VldE and OtsA(Sco) are amenable to
protein engineering through domain-swapping technology.
As predicted in most, if not all, GT-B GTs, the C-terminal do-
mains of OtsA and VldE are believed to interact with the sugar
or pseudosugar donors and the N-terminal domain interacts
with the acceptors. X-Ray crystal structures of VldE in complex
with GDP and validoxylamine A 70-phosphate showed interac-Chemistry & Biology 22,tions between purine (from GDP) and Arg321, Asn323, Asn361,
and Thr366 residues in the C-terminal domain, whereas in those
of E. coli OtsA showed interactions of the smaller pyrimidine
(from UDP) with Leu344, Ile295, Pro297, and His338 residues.
S. coelicolor OtsA, however, differs from E. coli OtsA in that it
prefers purine-derived NDP substrates. However, in contrast to
VldE, which strictly uses GDP-valienol, OtsA(Sco) can use both
GDP- and ADP-glucose (purine analogs) and, to a smaller extent,
UDP- and CDP-glucose (pyrimidine analogs).
Interestingly, despite ample evidence to support the distinc-
tive roles of the N- and C-terminal domains, we found, through
characterization of the chimeric proteins, that the N-terminal do-
mains of VldE and OtsA(Sco) also play a significant role in the
NDP-sugar preference. Chimera-1, which harbors the C-termi-
nal domain of OtsA(Sco) (which recognizes GDP-, ADP-, UDP-,
and CDP-glucoses), can only process GDP-glucose, whereas
chimera-2, which contains the C-terminal domain of VldE
(which recognizes only GDP-valienol), can accept GDP-, ADP-,
UDP-, and CDP-glucoses as substrates. Therefore, we propose
that, in addition to or in lieu of the C-terminal domain, the N-ter-
minal domains of OtsA and VldE play a significant role in select-
ing the type of NDP moiety of the donor sugars. As most of the
catalytic events in GT-B GTs occur in the interface of the two do-
mains, it is possible that the N-terminal domain is actually
involved in the primary recognition of the NDP-sugar(s), presum-
ably when the enzyme is in its ‘‘open’’ form, and the donor
substrate is subsequently directed to its binding pocket in the
C-terminal domain side of the interface.
The N-terminal domains of OtsA(Sco) and VldE are also
responsible for the selection of the acceptor molecules. Accord-
ingly, chimera-1, which consists of the N-terminal domain of
VldE and the C-terminal domain of OtsA(Sco), is able to utilize
GDP-glucose and validamine 7-phosphate as substrates. How-
ever, chimera-2, which consists of the N-terminal domain of
OtsA(Sco) and theC-terminal domain of VldE, is unable to couple
GDP-valienol and glucose 6-phosphate. In fact, this was not due
to the lack of activity of the enzyme, as it can catalyze the
coupling between GDP-glucose and glucose 6-phosphate to
give trehalose 6-phosphate. Therefore, we propose that a
strong nucleophilic group in the acceptor is necessary for a
successful coupling reaction involving a pseudosugar donor.
This was corroborated by incubating VldE with GDP-valienol
and 1-amino-1-deoxyglucose 6-phosphate. Although the ex-
pected product pseudoaminotrehalose could not be directly
observed, the identification of valienamine in the reaction mix-
tures with an active enzyme, but not in those with a heat-inacti-
vated enzyme, strongly suggests that pseudoaminotrehalose
was actually formed, but was spontaneously hydrolyzed to va-
lienamine (Figure 6). On the other hand, incubation of VldE with
GDP-valienol and validol 7-phosphate did not give any products,
further confirming the importance of the amino group in the reac-
tion. The notion that the nucleophilicity of the acceptor molecule
plays a significant role in the catalytic activity of PsGT enzymes is
consistent with the fact that all natural products whose forma-
tions are postulated to involve PsGTs contain amino linkages
(Mahmud, 2003).
Some important insights into the distinct substrate specificity
and reactivity of Ots(Sco), VldE, and their chimeras were also
gained from the kinetics studies (Figure 5; Table 1). First, it is724–733, June 18, 2015 ª2015 Elsevier Ltd All rights reserved 729
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Figure 5. Kinetic Parameters of VldE, OtsA,
Chimera-1, and Chimera-2 with Various
Substrates
Gray squares indicate very low catalytic reaction
observed. Black squares indicate no catalytic re-
action observed. Statistical measures are given in
Table 1. See also Figure S5.evident from the apparent specificity constants (kcat/Km values)
of OtsA(Sco) with various substrates that this enzyme is highly
optimized for its natural substrates, NDP-glucose and glucose
6-phosphate. OtsA(Sco) does not recognize GDP-valienol or
validamine 7-phosphate as substrates (Figure 4). Although the
enzyme uses validol 7-phosphate as an acceptor molecule, the
relative catalytic rate for this compound is significantly low,
despite their shared chair conformation, suggesting that the
ring oxygen in the sugar acceptor (glucose 6-phosphate) plays
a significant role for its higher binding affinity and/or the glycosyl-
ation reaction to take place efficiently.
Second, kinetics data also suggest that the PsGT VldE can
only optimally process GDP-valienol and validamine 7-phos-
phate. Although it can also use GDP-glucose as a donor mole-
cule (only when it is incubated with validamine 7-phosphate as
an acceptor), in comparison with GDP-valienol its affinity to the
enzyme and catalytic rate are significantly low. This unambigu-
ously confirmed the distinct substrate specificity of OtsA(Sco)
and VldE, and that VldE is a dedicated PsGT, not a GTwith broad
substrate specificity.
Third, compared with other substrates, GDP-valienol shows
unusually high binding affinity to VldE; in fact, it is considerably
higher than that of GDP-glucose to OtsA (Figure 5). This is likely
due to the half-chair conformation of the cyclohexene ring of
GDP-valienol, which resembles the oxocarbenium ion transition
state. Indeed, a number of natural and synthetic compounds
containing this structure have been used as potent competitive
inhibitors of biologically important sugar hydrolases. These
include the a-glucosidase inhibitor acarbose (used as an antidi-
abetic drug), the trehalase inhibitor validamycin A (used as an
antifungal), and the neuraminidase inhibitor oseltamivir (Tamiflu,
used as an anti-influenza drug). Interestingly, while the VldE
product validoxylamine A 70-phosphate also contains an oxocar-
benium ion-like structure, which arguably can inhibit the enzyme
activity, the apparent kcat/Km values of VldE remain relatively
high (2.0 s1 mM1 for GDP-valienol and 0.39 s1 mM1 for
validamine 7-phosphate). Thus, we speculate that the binding
affinity of the product to the enzyme is lower than that of theFigure 4. Characterization of VldE, OtsA, Chimera-1, and Chimera-2 with a Variety of Sugar an
(A–T) Sugar and pseudosugar donors and acceptors tested. The amino groups are depicted in their unpro
to show the possible C-N or C-O bond formations; they do not represent the stereospecificity of the reac
0.2–1.0 s1 mM1; (+), kcat/Km 0.02–0.2 s
1 mM1; (±), kcat/Km <0.02 s
1 mM1; (), no reaction. Natural or ex
boxes. See also Figures S4A–S4H.
Chemistry & Biology 22, 724–733, June 18, 2015substrate GDP-valienol as, in addition
to the oxocarbenium ion-like structure,
GDP-valienol has strong enzyme-GDP
hydrogen-bonding interactions, which is
more likely to have competitive advan-tages over validoxylamine A 70-phosphate. Indeed, the apparent
kcat/Km values of VldE for its natural substrates are about half of
those of OtsA (Figure 5; Table 1), although this may be merely
due to intrinsic factors related to the reactivity of the pseudosu-
gar donor.
Fourth, although both chimera-1 and chimera-2 are function-
ally active, their apparent kcat/Km values are relatively low. It is
unclear, however, whether this is due to the inherent nature of
engineered proteins of two different origins or to suboptimal
swapping sites in the linker regions. Nevertheless, we observed
a meaningful shift in the specificity constants of chimera-2 to
glucose 6-phosphate and validol 7-phosphate from those of
the parent protein OtsA(Sco). Compared with the distinct kcat/
Km values for glucose 6-phosphate and validol 7-phosphate in
OtsA(Sco), both substrates appear to have comparable kcat/Km
values in chimera-2. Whether this is due to the influence of
the C-terminal domain of VldE (in chimera-2) remains to be
investigated.
SIGNIFICANCE
To date there are more than 150,000 genes encoding pro-
teins across more than 90 known families of GTs listed in
the databases, and this number is growing rapidly. However,
only a fraction of them have been functionally characterized.
The challenge lies in the fact that not all of them are ‘‘true’’
GT enzymes. Our recent study revealed that some putative
GTs can catalyze a non-glycosidic C-N coupling in the
biosynthesis of pseudosugar-containing natural product.
The pseudosugar-transferase enzymes, or PsGTs, might
have evolved from ancestral GTs to the extent that they
can recognize non-sugars as donor substrates. However,
little is known about their substrate selectivity and catalytic
mechanisms. This lack of knowledge hinders the exploita-
tion of their full potential and may pose critical barriers to
progress in glycoscience, drug discovery, and related fields.
Here, we describe our success in engineering two chimeric
proteins from the GT OtsA(Sco) and the PsGT VldE and theird Pseudosugar Substrates
tonated forms and the curved arrows are intended
tions. (+++), kcat/Km >1.0 s
1 mM1; (++), kcat/Km
pected substrates for the enzymes are presented in
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See also Figures S6A and S6B.characterizations through comparative biochemical and
kinetics studies. The studies not only provide new insights
into the substrate selectivity and catalytic function of these
proteins, but also open up new opportunities in the broad
area of glycoscience and drug discovery, such as facilitating
the development of new technical capabilities to generate
carbohydrate mimetics, redesign glycoconjugates, and
create novel bioactive natural products.
EXPERIMENTAL PROCEDURES
Domain Swapping between VldE and OtsA(Sco)
DNA fragments of the VldE-N-terminal domain, VldE-C-terminal domain,
OtsA-N-terminal domain, and OtsA-C-terminal domain were amplified by
PCR using PfuTurbo DNA polymerase (Agilent Technology) and the listed
primer pairs (Table S1). The 50-end of the VldE-N-terminal domain DNA frag-
ment was digested with XhoI and the 30-end of the OtsA-C-terminal domain
DNA fragment was digested with EcoRI. The resulting DNA fragments
were ligated into the vector pRSET B (Invitrogen), predigested with XhoI and
EcoRI, to give pRSET-B-chimera-1. Similarly, the 50-end of OtsA-N-terminal
domain DNA fragment and the 30-end of VldE-C-terminal domain DNA frag-
ment were digested with BamHI and EcoRI, respectively, and ligated into
pRSET B, predigested with BamHI and EcoRI, to give pRSET-B-chimera-2.
The identity of the chimera-1 and chimera-2 genes was confirmed by Sanger
DNA sequencing in the Center for Genome Research and Biocomputing at
Oregon State University.
Chimera-1, Chimera-2, OtsA(Sco), OtsA(Eco), VldB, VldE,
and VldH Production and Purification
pRSET-B-chimera-1, pRSET-B-chimera-2, pRSET-B-otsA(Sco), pRSET-B-
otsA(Eco), pET20-vldB, pRSETB-vldE, and pRSETB-vldH were used to
transform E. coli BL21(DE3) pLysS. Transformants were grown overnight at
37C on LB agar plates containing ampicillin (100 mg/ml) and chloramphenicol
(25 mg/ml). A single colony was inoculated into LB medium (3 ml) containing
ampicillin (100 mg/ml) and chloramphenicol (25 mg/ml), and cultured at 37C
for 6 hr, and this seed culture (1ml) was transferred into a 500-ml flask contain-
ing LBmedium (100ml), containing ampicillin (100 mg/ml) and chloramphenicol
(25 mg/ml), and grown at 28C until OD600 reached 0.6. The temperature was
then reduced to 18C, and after 2 hr of adaptation, isopropyl-b-D-thiogalacto-
pyranoside was added to a final concentration of 0.1 mM to induce the732 Chemistry & Biology 22, 724–733, June 18, 2015 ª2015 ElsevierC-terminal hexahistidine-tagged VldB and the N-terminal hexahistidine-
tagged chimera-1, chimera-2, OtsA(Sco), OtsA(Eco), VldE, and VldH proteins.
After further growth for 14 hr, the cells were harvested by centrifugation
(5,000 rpm, 10 min, 4C) and stored at 80C until use.
Cell pellets from 50ml of culture were washed with binding (B) buffer (40mM
NaH2PO4 [pH 8.0], 300 mM NaCl, 10 mM imidazole) (1 ml) and centrifuged
(4,000 rpm, 10 min, 4C). Then, B buffer (1 ml) was added and the mixtures
were sonicated (8 W, 15 s, four times). After centrifugation (14,500 rpm,
20 min, 4C), the supernatant was purified using an Ni-NTA spin column
(Qiagen) at 4C using washing (W) buffer (40 mM NaH2PO4 [pH 8.0], 300 mM
NaCl, 20 mM imidazole) (2 3 600 ml) and elution (E) buffer (40 mM NaH2PO4
[pH 8.0] containing 300 mM NaCl and 500 mM imidazole) (500 ml). Eluted
proteins were dialyzed against dialysis buffer (10 mM Tris-HCl [pH 7.5],
0.1 mM DTT, 1 mM MgCl2) (1 l) three times for 3 hr each. Purified proteins
were analyzed by SDS-PAGE and concentrated by ultrafiltration using Amicon
YM-10 (Millipore). Protein concentration was determined using the Bradford
assay (Bio-Rad) using BSA as a standard.
Preparation of NDP-Valienol
NDP-valienol was prepared according to a reported procedure (Yang et al.,
2011). Briefly, valienol 1-phosphate (6 mM) was incubated with ATP, GTP,
CTP, UTP, or dTTP (6 mM) in the presence of VldB or RmlA-L89T (10 mM)
and MgCl2 (10 mM) in Tris-HCl buffer (50 mM, pH 7.5) at 30
C, and the
progress of the reactions was monitored by ESI-MS. After 4 hr, the reactions
were quenched with an equal volume of MeOH and centrifuged (14,500 rpm,
5 min, 4C).
Chemical syntheses of validol 7-phosphate and 1-amino-1-deoxyglucose
6-phosphate are described in Supplemental Experimental Procedures.
Glycosyltransferase Assays
The catalytic activity of VldE, OtsA(Sco), OtsA(Eco), chimera-1, and chimera-2
was examined using NDP-glucoses or NDP-valienols as sugar donor and
glucose 6-phosphate, validamine 7-phosphate, or validol 7-phosphate as
sugar acceptor. Each reaction (100 ml) contained donor substrate (5 mM),
acceptor substrate (5 mM), protein (10 mM), MgCl2 (10 mM), and Tris-HCl
(50 mM, pH 7.5). The reaction mixtures were incubated at 30C and aliquots
(10 ml) of the reactions were collected at 1, 2, 3, 5, and 12 hr, quenched
with an equal volume of MeOH, and centrifuged (14,500 rpm, 5 min, 4C).
The supernatants were analyzed by ESI-MS.
HPLC Analysis of VldB, RmlA-L89T, VldE, and Chimera-1 Products
The reactions were quenched by adding two volumes of MeOH and
centrifuged. The supernatants were analyzed by HPLC (Shimazu SPD-20A
system) with a C18 column (YMC-Pack ODS-A, 250 3 4.6 mm, 5 mm) using
0.5% MeOH in H2O containing 10 mM NH4HCO3 as eluent at a flow rate of
1 ml/min. Elution profiles were monitored at 210 nm.
Kinetic Analysis of VldE, OtsA, Chimera-1, and Chimera-2
Km and kcat values for VldE, OtsA, chimera-1, and chimera-2 were determined
by using the phosphopyruvate kinase (PK) and lactate dehydrogenase (LDH)
coupled assay (Sigma-Aldrich). The reaction mixture (100 ml) contained Tris-
HCl buffer (50 mM, pH 7.5), MgCl2 (5 mM), VldE (1 mM), phosphoenolpyruvate
(1.5 mM), reduced nicotinamide adenine dinucleotide (NADH) (0.5 mM), PK
(37 U), and LDH (46 U), in addition to a serial dilution of the donor substrate
and 2 mM of the acceptor substrate for the determination of the value for
the donor substrate, and a serial dilution of the acceptor substrate and
2 mM donor substrate for the determination of the value for acceptor sub-
strate. Oxidation of NADH to NAD+ was monitored in 96-well plates using a
spectrophotometric microplate reader at 340 nm. Reaction mixtures lacking
the enzyme were used as negative control (blank). The data were collected
in triplicate. A Michaelis-Menten plot (SigmaPlot, Systat Software) was used
for determination of Km and kcat values.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
one table, and six figures and can be found with this article online at http://
dx.doi.org/10.1016/j.chembiol.2015.04.021.Ltd All rights reserved
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